Answer
No, patients who developed pure red cell aplasia following treatment with any erythropoietin should not receive Eprex (epoetin alfa) or any other erythropoietin.
Sources for this answer
- Eprex 40,000 IU/ml solution for injection in pre-filled syringeJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.3 Contraindications · Version 20Document updated
Sources checked